Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 195

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis

Open access
Ito, M., Haruma, K., Kamada, T., Mihara, M., Kim, S., Kitadai, Y., Sumii, M., Tanaka, S., Yoshihara, M., Chayama, K. · 2002 · Alimentary Pharmacology & Therapeutics

Abstract

SUMMARY: Aim : To investigate the effect of the eradication of Helicobacter pylori on histological gastritis. Methods : Twenty‐six patients with moderate to severe atrophy received successful eradication therapy of H.pylori. Four patients dropped out and 22 were followed up prospectively for 5 years. The grades of gastritis were estimated from gastric biopsy specimens. The grade of intestinal metaplasia was also evaluated by dye‐endoscopy using methylene blue (methylthioninium chloride). The serum levels of pepsinogen, gastrin and anti‐parietal cell antibody were also determined. Results : The grades of atrophy decreased in patients with successful eradication therapy in the gastric corpus (before vs. 5 years after eradication, 2.09 ± 0.15 vs. 0.91 ± 0.17; P < 0.01) and in the antrum (2.14 ± 0.17 vs. 1.36 ± 0.17; P < 0.01). The levels of intestinal metaplasia were also decreased in the corpus (0.91 ± 0.24 vs. 0.50 ± 0.16; P < 0.05) and in the antrum (1.41 ± 0.20 vs. 1.00 ± 0.16; P < 0.05), which was also demonstrated by the methylene blue (methylthioninium chloride) staining method (33.4 ± 8.2% vs. 23.0 ± 6.5%; P < 0.05). The improvement of corpus atrophy correlated well with the high serum level of pepsinogen I (P = 0.005), but showed no correlation with the levels of anti‐parietal cell antibody. Conclusions : These results suggest that gastric atrophy and intestinal metaplasia are reversible events in some patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.2002.01311.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 195

Metadata

Authors
Ito, M., Haruma, K., Kamada, T., Mihara, M., Kim, S., Kitadai, Y., Sumii, M., Tanaka, S., Yoshihara, M., & Chayama, K.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2002-08
Volume
16
Issue
8
Pages
1449-1456
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2163792620
Cited by
195
References
2
FWCI
11.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis. https://app.cochat.ai/papers/10.1046/j.1365-2036.2002.01311.x
The paper
Ito, M., Haruma, K., Kamada, T., Mihara, M., Kim, S., Kitadai, Y., Sumii, M., Tanaka, S., Yoshihara, M., & Chayama, K. (2002). Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2002.01311.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.